Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumors Interventions: Drug: Ripretinib; Drug: binimetinib Sponsor: Deciphera Pharmaceuticals LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials